Posted on December 5, 2018December 7, 2018 by Pulse AssentISO/TS 20399-1:2018 Biotechnology. Ancillary materials present during the production of cellular therapeutic products General requirements Link: ISO/TS 20399-1:2018 Biotechnology. Ancillary materials present during the production of cellular therapeutic products General requirements Source: BSI Standards Related Posts:Government to look at ways new high-tech materials…New laws to introduce digital labelling for…Businesses to be given UK product marking flexibilityRed tape cut for thousands of growing businessesUK Government announces extension of CE mark…
